BIOCAD

BIOCAD is a vertically integrated biopharmaceutical company which excels at full-cycle drug discovery and development, as well as commercial-scale manufacturing of biological and chemical therapeutics for the treatment of cancer and autoimmune disorders. BIOCAD's advanced MabNext program is focused on the development of monoclonal antibodies without non-human sequences with high specific activity. The company also has several high-quality mAb biosimilars on the world market.
Location: 

Contact details

Svyazi 34-A
Strelna
198515
Saint-Petrsburg
Russia